What Is Benign Prostatic Enlargement (BPE/BPH)?
Request Call Back
Overview
Benign Prostatic Enlargement (BPE)—also called Benign Prostatic Hyperplasia (BPH)—is a non-cancerous increase in the size of the prostate gland. The prostate is a walnut-sized organ that sits just below the bladder and surrounds the first segment of the urethra (the urine channel). As men age, hormonal and cellular changes can cause the prostate to enlarge.
Because the prostate encircles the urethra, enlargement can narrow the urinary channel, leading to lower urinary tract symptoms (LUTS) such as weak stream, hesitancy, urgency, and nocturia (night-time urination). Management ranges from watchful waiting and lifestyle changes to medications, minimally invasive therapies, and surgery—planned individually based on symptom severity, prostate size, and patient preference.
At MedicalPoint Hospital, our urologists deliver evidence-based, personalized care using advanced diagnostics and modern treatment options, including laser enucleation and prostate artery embolization where appropriate.
What Causes Prostate Enlargement?
BPE results from a complex interplay of aging, hormonal shifts, and genetic and metabolic factors that stimulate prostate cell growth—especially in the transition zone around the urethra.
Key contributors include:
- Aging: BPE is uncommon before 40; prevalence increases with each decade of life. Cellular remodeling and stromal–epithelial interactions drive growth over time.
- Hormonal changes: Testosterone converts to dihydrotestosterone (DHT) in the prostate via 5-alpha-reductase. DHT promotes prostatic tissue growth; age-related shifts in androgen–estrogen balance may also contribute.
- Family history (genetic predisposition): First-degree relatives with early-onset BPH increase the likelihood of developing symptomatic enlargement.
- Metabolic factors: Obesity, insulin resistance/diabetes, and features of metabolic syndrome correlate with greater prostate volume and irritative symptoms.
- Lifestyle/vascular factors: Sedentary behavior, high-salt diets, and poor blood pressure and lipid control can aggravate symptoms.
Important: BPE is not prostate cancer. However, both conditions may coexist, and evaluation at MedicalPoint includes careful cancer risk assessment when indicated.
Symptoms of Benign Prostatic Enlargement
When the enlarging prostate compresses the urethra or irritates the bladder, patients may experience voiding (obstructive) and storage (irritative) symptoms:
Voiding/Obstructive symptoms
- Weak or intermittent urinary stream
- Hesitancy (difficulty starting) or straining to void
- Prolonged urination time
- Post-void dribbling
- Sensation of incomplete bladder emptying
Storage/Irritative symptoms
- Frequency (urinating more often than usual)
- Urgency (sudden compelling need to urinate)
- Nocturia (waking at night to void)
- Urgency incontinence (leakage before reaching the toilet)
- Occasionally hematuria (blood in urine) or malodorous/cloudy urine if infection occurs
Symptom severity can fluctuate. Untreated, BPE may lead to urinary retention, recurrent urinary tract infections (UTIs), bladder stones, or progressive bladder/kidney dysfunction.
How Is BPE Diagnosed?
At MedicalPoint Hospital, evaluation is structured, comfortable, and patient-centered. Your urologist may recommend:
- Detailed history & physical examination: Includes validated questionnaires such as the International Prostate Symptom Score (IPSS) and a digital rectal exam (DRE) to assess prostate texture and approximate size.
- Urinalysis & urine culture: Screens for infection, blood, or glucose/ketones that may mimic or exacerbate symptoms.
- Prostate-Specific Antigen (PSA) blood test: PSA can be elevated in BPE, prostatitis, or prostate cancer; levels are interpreted in clinical context (age, prostate size, prior PSA trends).
- Uroflowmetry: Measures flow rate and pattern during urination.
- Post-void residual (PVR): Ultrasound or catheter-based measurement of urine left in the bladder after voiding.
- Transabdominal or transrectal ultrasound (TRUS): Estimates prostate volume, evaluates anatomy, and helps plan therapy.
- Cystoscopy (when indicated): Direct visualization of the urethra/bladder if hematuria, strictures, stones, or surgical planning are concerns.
- Prostate MRI and/or biopsy (selective): Performed when there is a clinical suspicion of cancer (persistently elevated PSA, abnormal DRE, concerning imaging).
PSA note: A higher PSA does not automatically mean cancer; BPE and inflammation can raise PSA. Conversely, a normal PSA does not completely exclude cancer. Shared decision-making with your urologist is essential.
Treatment Options at MedicalPoint Hospital
1) Active Surveillance (“Watchful Waiting”) & Lifestyle Measures
Appropriate for mild, non-bothersome symptoms. We monitor symptom scores and bladder function while recommending:
- Limiting evening fluids, caffeine, and alcohol
- Bladder training and timed voiding
- Weight management, regular physical activity, and cardiometabolic risk control
- Treating constipation and avoiding decongestants with alpha-agonists that may worsen retention
2) Medications
Medications are individualized based on symptom profile, prostate size, blood pressure, and sexual function goals.
- Alpha-blockers (e.g., tamsulosin, alfuzosin): Relax prostate/bladder neck smooth muscle to improve flow quickly. Possible side effects: dizziness, nasal congestion, ejaculatory changes.
- 5-alpha-reductase inhibitors (e.g., finasteride, dutasteride): Shrink the prostate by lowering DHT; best for larger glands; benefits accrue over months. May reduce PSA by ~50% (your doctor adjusts PSA interpretation accordingly).
- Combination therapy: Alpha-blocker + 5-ARI for men with moderate–severe symptoms and larger prostates.
- Antimuscarinics or β3-agonists (e.g., mirabegron) for predominant urgency/frequency when flow is adequate and PVR is low.
- Phosphodiesterase-5 inhibitor (tadalafil) may relieve LUTS and help concomitant erectile dysfunction in selected patients.
3) Minimally Invasive Office-Based/Day-Case Therapies
Considered when medications are ineffective, poorly tolerated, or undesired:
- Prostate Artery Embolization (PAE): Interventional radiology procedure that reduces prostatic blood flow to shrink the gland and alleviate symptoms—no surgical incision.
- Prostatic Urethral Lift (e.g., UroLift®) or water-vapor thermal therapy (e.g., Rezūm™)—availability depends on anatomy and local protocols; these can improve symptoms with preservation of sexual function in selected patients.
4) Surgical/Endoscopic Options
For moderate–severe symptoms, recurrent retention, stones, recurrent infections, or kidney impairment:
- TURP (Transurethral Resection of the Prostate): Long-standing standard for moderate-sized prostates; resects obstructing tissue via endoscope.
- Laser procedures (performed at MedicalPoint depending on individual anatomy and prostate size):
- HoLEP (Holmium Laser Enucleation of the Prostate)
- ThuLEP (Thulium Laser Enucleation of the Prostate)
- GreenLight™ PVP (Photoselective Vaporization)
These techniques typically provide durable relief with less bleeding and shorter catheterization than some traditional surgeries.
- Open/robotic simple prostatectomy: Reserved for very large glands when endoscopic methods are not suitable.
Your MedicalPoint urologist will discuss benefits, risks, recovery expectations, and sexual/urinary side-effect profiles to select the right treatment for you.
Frequently Asked Questions (FAQ)
Is BPE dangerous if left untreated?
BPE itself is non-cancerous, but untreated obstruction may lead to acute urinary retention, recurrent UTIs, bladder stones, worsening bladder function, and in advanced cases kidney damage. Seek evaluation if your symptoms are new or worsening.
Does BPE increase the risk of prostate cancer?
BPE does not cause cancer. However, both conditions may occur together. That’s why age-appropriate PSA testing and clinical assessment are important parts of your care at MedicalPoint.
What lifestyle changes can help my symptoms?
- Reduce evening fluids and caffeinated/alcoholic beverages
- Achieve a healthy weight and exercise regularly
- Optimize blood pressure, cholesterol, and diabetes control
- Manage constipation and review medications that may worsen symptoms with your doctor
How do doctors decide between pills, PAE, laser surgery, or TURP?
We consider your symptom severity (IPSS), prostate size and shape, PVR/flow results, overall health, sexual function priorities, and your preference. The goal is maximizing relief with the least side effects.
Will treatment affect sexual function?
Some therapies (e.g., alpha-blockers, TURP, or certain lasers) can cause retrograde ejaculation (semen flows into the bladder). Erectile function is often preserved, and many men experience improved quality of life after relieving obstruction. Your urologist will review procedure-specific risks in detail.
Why Choose MedicalPoint Hospital?
- Expert Urology Team: Fellowship-trained surgeons and interventional specialists experienced in the full spectrum of BPE management.
- Advanced Diagnostics: IPSS-guided evaluation, uroflowmetry, ultrasound/TRUS, and precise imaging for tailored plans.
- Modern Therapies: Access to PAE, laser enucleation (HoLEP/ThuLEP), and GreenLight PVP, alongside medical and conventional surgical options.
- Patient-Centered Care: Shared decision-making that aligns with your symptoms, goals, and lifestyle—backed by comprehensive follow-up and rehabilitation when needed.
If you experience urinary changes, don’t delay evaluation. Early assessment can prevent complications and expand your treatment choices.
Other Conditions
Life During and After IVF Treatment: What Patients Should Know
Prostate Cancer Treatment in Turkey
Coronary CT Angiography: Advanced Non-Invasive Imaging for Heart and Coronary Artery Health
Toxic Shock Syndrome and Tampon Use: What Women Should Know About This Rare but Serious Condition
Neurosurgery and Brain Health: Modern Approaches to Complex Neurological Conditions
Living with Allergies: Daily Management, Nutrition, and Long-Term Strategies
Hypertension Management and Lifestyle Changes
IVF (In Vitro Fertilization) Abroad
Urology
The Department of Urology is structured to cover each sub-branch of urology. In our department, in addition to all urological diseases in the field of cancer, prostate diseases, stone diseases, and applications related to women’s and children’s urology are meticulously applied by specialist physicians.
